At the same time, protective myocytic factors such as IGF-1 and IL-15 are downregulated, and the muscle response to exercise-induced myogenic IL-6 in cancer patients shifts from anti-inflammatory to pro-inflammatory characteristics. The gene discussed is IL6; the disease is cancer.